Scilex Holding Company

NASDAQ: SCLX
Share price (12/23/24): $0.46
Market cap (12/23/24): $87.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 161 pages Agreement and Plan of Merger Dated as of August 30, 2024 by and Among Denali Capital Acquisition Corp., Denali Merger Sub Inc., and Semnur Pharmaceuticals, Inc

from 8-K 7 pages Amendment No.1 to Agreement and Plan of Merger

from 425 7 pages Amendment No.1 to Agreement and Plan of Merger

from S-4/A 28 pages Recitals

from S-4/A 6 pages Bill of Sale and Assignment and Assumption Agreement

from S-4/A 3 pages Amendment No. 1

from S-4/A 106 pages Agreement and Plan of Merger by and Among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, Solely as the Equityholders’ Representative And, Solely With Respect to Section 1.8(a), Section 3.11 and Article X, Sorrento Therapeutics, Inc. Dated as of March 18, 2019

from 8-K 171 pages Agreement and Plan of Merger Dated as of March 17, 2022 by and Among Vickers Vantage Corp. I, Vantage Merger Sub Inc., and Scilex Holding Company

from 425 171 pages Agreement and Plan of Merger Dated as of March 17, 2022 by and Among Vickers Vantage Corp. I, Vantage Merger Sub Inc., and Scilex Holding Company